Tuesday, December 16, 2008
Preventing Metastasis To 'Stop Cancer From Killing People'
Metastasis is the ability of cancer cells to spread from a primary site, to form tumours at distant sites. It is a complex process in which cell motility and invasion play a fundamental role. Essential to our understanding of how metastasis develops is identification of the molecules, and characterisation of the mechanisms that regulate cell motility. Hitherto, these mechanisms have been poorly understood.
Clatterbridge Centre For Oncology Ranked As One Of The Best Healthcare Organisations To Work For In The UK
Clatterbridge Centre for Oncology is one of the Top 100 healthcare organisations to work for in the UK according to a survey by the Health Service Journal. The survey asked employees at the Centre a range of questions and the Centre has been included in the Top 100 list! The final results will be announced in March 2009, when the Centre will find out where they came in the top 100.
East Surrey Hospital Reports Cases Of Winter Vomiting Virus, England
Holmwood and Godstone wards have been closed to incoming patients after 18 people at the hospital have developed symptoms of winter vomiting virus. Tests are now being done to find the cause and the wards will remain shut until all symptoms of the bug have cleared. Members of the public are being asked to consider the necessity of their visit to the hospital. No one should visit if they themselves have been unwell within the last week.
Tau Protein Expression Predicts Breast Cancer Survival -- Though Not As Expected
Expression of the microtubule-binding protein Tau is not a reliable means of selecting breast cancer patients for adjuvant paclitaxel chemotherapy, according to research led by The University of Texas M. D. Anderson Cancer Center. Presented Dec. 13, at the CRTC-AACR San Antonio Breast Cancer Symposium, the researchers found that Tau expression does predict survival, yet in an unexpected way. In earlier neoadjuvant studies, investigators from M. D.
Low Income Men Diagnosed More Often With Advanced Prostate Cancer, The Journal Of Urology
Coincident with the widespread adoption of PSA screening, the proportion of American men diagnosed with organ-confined, low risk prostate cancer has increased significantly during the last two decades. In a study scheduled for publication in the February 2009 issue of
Possible Therapeutic Target For Pancreatic Cancer
A possible new therapeutic target for pancreatic cancer, the most lethal form of human cancer, has been identified in the proteins whose DNA recipe comes from gene, "Seven-In-Absentia," according to researchers at the American Society for Cell Biology (ASCB) 48th Annual Meeting, Dec. 13-17, 2008 in San Francisco.
ABRAXANE In Combination With Gemcitabine And Epirubicin Evaluated As Neoadjuvant Treatment For Patients With Locally Advanced Breast Cancer
Abraxis BioScience, Inc. (NASDAQ:ABII), a fully integrated, global biotechnology company, today announced the presentation of preliminary results from a single-arm, open-label, Phase II clinical trial evaluating ABRAXANE® for Injectable Suspension (paclitaxel protein-bound particles for injectable suspension) (albumin- bound) in combination with gemcitabine and epirubicin for the treatment of patients with locally advanced breast cancer (neoadjuvant treatment).
Study Finds That Low-Income Men Are More Likely To Be Diagnosed With Advanced Prostate Cancers
Low-income men are more likely to present with advanced prostate cancers, most likely because they don't receive screening services shown to reduce the diagnosis of later-stage cancers, a UCLA study found. The study focused on a group of disadvantaged men enrolled in the state's IMPACT (Improving Access, Counseling and Treatment for Californians with Prostate Cancer) program, which provides high-quality care to poor, underinsured and uninsured men.
Monday, December 15, 2008
Allergists Respond To FDA Committee Recommendation On Asthma Medication, Encourage Patients With Questions To Contact Physicians
IDO2 An Active Enzyme To Target In Pancreatic Cancer
An enzyme that is overexpressed in pancreatic cancer cells may hold the key to successfully treating the disease with targeted immunotherapy, researchers from Thomas Jefferson University reported at the 2008 Annual Meeting of the Southern Surgical Association.
Complete news at...A University of Iowa study provides insight into a calcium-sensing enzyme already known to play a role in irregular heartbeats and other critical functions. The researchers showed that the enzyme, calmodulin kinase II (CaM kinase II), contributes to arrhythmia in an extremely rare disease called Timothy syndrome and that inhibiting the enzyme prevents irregular heartbeats.
Complete news at...One in 35 people with colon cancer carry a hereditary form of the disease, according to the second of two studies led by researchers at The Ohio State University Comprehensive Cancer Center.
Based on the finding, researchers recommend screening all colon-cancer patients for Lynch syndrome, the most common inherited form of colon cancer.
Complete news at...A UCLA study shows for the first time how microscopic crystals form sound and gravity sensors inside the inner ear. Located at the ends of cilia — tiny cellular hairs in the ear that move and transmit signals — these crystals play an important role in detecting sound, maintaining balance and regulating movement.
Dislodged ear crystals are to blame for the most common form of vertigo. Known as benign paroxysmal positional vertigo, the disorder plagues up to 10 percent of people older than 60 and causes 20 percent of patients' dizziness complaints.
Complete news at...A University of Iowa researcher and colleagues at the University of Michigan have discovered a direct link between disruption of a critical cellular housekeeping process and fatty liver disease, a condition that causes fat to accumulate in the liver.
Complete news at...A novel angled gantry approach to coronary CT angiography reduced radiation exposure to the breast by more than 50%, according to Thomas Jefferson University researchers.
Ethan Halpern, M.D., associate professor of Radiology at Jefferson Medical College of Thomas Jefferson University in Philadelphia, presented the research at the 94th Scientific Assembly and Annual Meeting of the Radiological Society of North America.
Complete news at...An automated system worked well in helping manage routine chemotherapy side effects in women with metastatic breast cancer, according to research conducted in part at Beaumont Hospital in Royal Oak.
One hundred ninety-four women with an average age of 50 were assessed on 15 symptoms ranging from anxiety to fatigue. Half were randomly assigned to an automated system.
Patients received weekly phone calls for the first four weeks, were called during week six and received a final call during week eight. More than 85 percent of the participants completed the study.
Complete news at...